Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)
Close on Nov 18, 2026Market cap $3.66BP/E –Yield –
Xenon Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Xenon Pharmaceuticals's pe ratio was 7.3× on Oct 30, 2015.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Oct 30, 2015 | 7.3× | +2.2 |
| 2014 | Dec 31, 2014 | 5.1× | – |
See a number that looks wrong?